Our findings demonstrate that TREX1 depletion triggers an intrinsic innate immune response through cGAS-STING pathway activation in multiple SCLC chemoresistant models, which leads to decreased cell proliferation rate and survival. Here, STING1 is linked to small cell lung carcinoma.